Related references
Note: Only part of the references are listed.Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
Kaj Blennow et al.
BRAIN (2020)
Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease
Nicolas R. Barthelemy et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report
Joseph F. Arboleda-Velasquez et al.
NATURE MEDICINE (2019)
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease
Claudia Cicognola et al.
ACTA NEUROPATHOLOGICA (2019)
Biomarkers for tau pathology
Michael Scholl et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
Ruben Smith et al.
JAMA NEUROLOGY (2019)
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2019)
Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
Zhuohao He et al.
NATURE MEDICINE (2018)
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
Renaud La Joie et al.
NEUROLOGY (2018)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
Sarah L. DeVos et al.
BRAIN (2018)
Tau filaments in neurodegenerative diseases
Michel Goedert
FEBS LETTERS (2018)
Comparing F-18-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
Niklas Mattsson et al.
NEUROLOGY (2018)
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato et al.
NEURON (2018)
Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
Taeko Kimura et al.
FRONTIERS IN NEUROSCIENCE (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze et al.
NEUROLOGY (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2017)
Enhanced Tau Aggregation in the Presence of Amyloid β
Rachel E. Bennett et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
Bruno Vasconcelos et al.
ACTA NEUROPATHOLOGICA (2016)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
Jasmeer P. Chhatwal et al.
NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Increased amyloidogenic APP processing in APOE ε4-negative individuals with cerebral β-amyloidosis
Niklas Mattsson et al.
NATURE COMMUNICATIONS (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
Tau-aggregation inhibitor therapy for Alzheimer's disease
Claude M. Wischik et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Models of β-amyloid induced Tau-pathology: the long and folded road to understand the mechanism
Ilie-Cosmin Stancu et al.
MOLECULAR NEURODEGENERATION (2014)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
Luis F. Maia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Kiran Bhaskar et al.
NEURON (2010)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures
WH Zheng et al.
NEUROSCIENCE (2002)
Share Paper
